tiprankstipranks
Advertisement
Advertisement
Esperion presents new data from CLEAR Outcomes, CLEAR Phase 2 study
PremiumThe FlyEsperion presents new data from CLEAR Outcomes, CLEAR Phase 2 study
2M ago
Esperion Therapeutics’ 10-Q Forward-Looking Statements Highlight Significant Uncertainty and Investor Risk
Premium
Company Announcements
Esperion Therapeutics’ 10-Q Forward-Looking Statements Highlight Significant Uncertainty and Investor Risk
2M ago
EXE, IP, ESPR, CMPS, TNXP Trending With Analysts
Premium
Weekend Updates
EXE, IP, ESPR, CMPS, TNXP Trending With Analysts
2M ago
Esperion downgraded to Hold from Buy at Jefferies
PremiumThe FlyEsperion downgraded to Hold from Buy at Jefferies
3M ago
Esperion downgraded to Neutral from Overweight at Piper Sandler
Premium
The Fly
Esperion downgraded to Neutral from Overweight at Piper Sandler
3M ago
Esperion agrees to $1.1 billion ARCHIMED buyout
Premium
Company Announcements
Esperion agrees to $1.1 billion ARCHIMED buyout
3M ago
Esperion Therapeutics: Reinforced Buy Rating on Strengthened Investment Story and Conference-Driven Upside Catalysts
PremiumRatingsEsperion Therapeutics: Reinforced Buy Rating on Strengthened Investment Story and Conference-Driven Upside Catalysts
3M ago
Esperion Completes Corstasis Acquisition, Expands Cardiovascular Portfolio
Premium
Company Announcements
Esperion Completes Corstasis Acquisition, Expands Cardiovascular Portfolio
4M ago
Esperion, Athyrium Capital enter $50M royalty financing agreement
Premium
The Fly
Esperion, Athyrium Capital enter $50M royalty financing agreement
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100